http://en.ascentagepharma.com/ A Leader in the Design of Small Molecule Therapeutics that Target Protein-Protein Interactions Ascentage is a globally-focused clinical-stage biopharmaceutical company developing first- and best-in-class targeted therapeutics for cancers, hepatitis B & age-related diseases.
3 Distinct Apoptosis Targets
7 Product Candidates in Clinical Development
20 Years in PPI Apoptosis Research2 : GS(14)@2018-08-21 06:32:52